Yüklüyor......
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Immune checkpoint blockade (ICB) has a limited effect on colorectal cancer, underlining the requirement of co‐targeting the complementary mechanisms. Here, we identified prostaglandin E2 (PGE(2)) receptor 4 (EP4) as the master regulator of immunosuppressive myeloid cells (IMCs), which are the major...
Kaydedildi:
| Yayımlandı: | EMBO Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799360/ https://ncbi.nlm.nih.gov/pubmed/33283987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012798 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|